Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

NCT06150664

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +37 more
Locations
  • D&H Cancer Research Center Margate, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • University Cancer & Blood Center Athens, Georgia, United States
View Trial Details
Recruiting

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

NCT04671667

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Bellflower Bellflower, California, United States
View all 178 locations
View Trial Details
Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 225 locations
View Trial Details
Recruiting

Intratumoral N17350 in Advanced Solid Tumors

NCT07339176

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Triple-Negative, +33 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

NCT06589804

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +38 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Fremont - Rideout Cancer Center Marysville, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
View all 192 locations
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

NCT07026474

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Klinikum Chemnitz gGmbH, Klinik für Radioonkologie Chemnitz, Germany
  • Klinikum Darmstadt GmbH, Institut für Radioonkologie und Strahlentherapie Darmstadt, Germany
  • Gemeinschaftspraxis Hämatologie-Onkologie Dresden Dresden, Germany
  • Helios Klinikum Erfurt, Klinik für Strahlentherapie Erfurt, Germany
View all 21 locations
View Trial Details

Related conditions